Clinical Trial Update: A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for LONSURF in recurrent/metastatic nasopharyngeal carcinoma is reported, status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN